Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dimethyl Sulfoxide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethyl Sulfoxide SCHEMBL7933303 | 1.00 | — | — | |
| Dimethyl Sulfoxide SCHEMBL8906090 | 1.00 | — | — | |
| Dimethyl Sulfoxide SCHEMBL8369214 | 1.00 | — | — | |
| Dimethyl Sulfoxide SCHEMBL15611373 | 0.94 | — | — | |
| Dimethyl Sulfoxide SCHEMBL11743912 | 0.94 | — | — | |
| Dimethyl Sulfoxide SCHEMBL10879805 | 0.94 | — | — | |
| Dimethyl Sulfoxide SCHEMBL17141374 | 0.93 | — | — | |
| Dimethyl Sulfoxide SCHEMBL2856303 | 0.93 | — | — | |
| Dimethyl Sulfoxide SCHEMBL3409 | 0.93 | — | — | |
| Dimethyl Sulfoxide SCHEMBL59 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 521 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118360685-A | Collagen fiber with mesoscale aggregate as structural unit for biomedical material and preparation method thereof | 郑州大学 | 2024-07-19 | — | — | CN | claimed |
| CN-118271384-A | Method for preparing progesterone | 淮北师范大学 | 2024-07-02 | — | — | CN | claimed |
| CN-118239883-A | Preparation method of lysine-specific demethylase 1 (LSD 1) inhibitor | 江苏联环药业股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-113292624-B | Synthesis method of abiraterone acetate impurity | 四川伊诺达博医药科技有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-115996922-A | Salts of Rho-associated protein kinase inhibitors, solid forms thereof, methods of making and uses thereof | 北京泰德制药股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-113979906-A | Simple method for preparing dimethyl disulfide and deuterated dimethyl disulfide | 北京工商大学 | 2022-01-28 | — | — | CN | claimed |
| CN-113979904-A | Simple method for preparing dimethylthiomethyl methane and deuterated dimethylthiomethyl methane | 北京工商大学 | 2022-01-28 | — | — | CN | claimed |
| US-11149026-B2 | Solid state forms of 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione hydrochloride and their processes for the preparation thereof | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2021-10-19 | — | — | US | claimed |
| CN-113402411-A | Oxidation reaction-based synthesis method of propyzamide | 深圳市谦陌通辰实验有限公司 | 2021-09-17 | — | — | CN | claimed |
| CN-113292624-A | Synthesis method of abiraterone acetate impurity | 四川伊诺达博医药科技有限公司 | 2021-08-24 | — | — | CN | claimed |
| EP-0730570-B1 | METHOD FOR MAKING INTERMEDIATES USEFUL IN SYNTHESIS OF RETROVIRAL PROTEASE INHIBITORS | SEARLE & CO (US) | 2000-04-19 | — | — | EP | claimed |
| US-6022996-A | Method for making intermediates useful in synthesis of retroviral protease inhibitors | G. D. SEARLE & CO. (US) | 2000-02-08 | — | — | US | claimed |
| EP-0855388-A2 | Method for making intermediates useful in synthesis of retroviral protease inhibitors | G.D. SEARLE & CO. (US) | 1998-07-29 | — | — | EP | claimed |
| EP-0730570-A1 | METHOD FOR MAKING INTERMEDIATES USEFUL IN SYNTHESIS OF RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1996-09-11 | — | — | EP | claimed |
| EP-0641333-B1 | METHOD FOR MAKING INTERMEDIATES USEFUL IN SYNTHESIS OF RETROVIRAL PROTEASE INHIBITORS | SEARLE & CO (US) | 1996-08-14 | — | — | EP | claimed |
| EP-0541593-B1 | CYCLOPENTANE DERIVATIVES, PROCESS FOR PRODUCING THEM AND THEIR PHARMACEUTICAL USE | SCHERING AG (DE) | 1995-09-13 | — | — | EP | claimed |
| WO-1995014653-A1 | METHOD FOR MAKING INTERMEDIATES USEFUL IN SYNTHESIS OF RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1995-06-01 | — | — | WO | claimed |
| EP-0641333-A1 | METHOD FOR MAKING INTERMEDIATES USEFUL IN SYNTHESIS OF RETROVIRAL PROTEASE INHIBITORS. | SEARLE & CO (US) | 1995-03-08 | — | — | EP | claimed |
| US-5292921-A | Process for the enantioselective preparation of phenylisoserine derivatives | RHONE-POULENC RORER S.A. (FR) | 1994-03-08 | — | — | US | claimed |
| WO-1993023388-A1 | METHOD FOR MAKING INTERMEDIATES USEFUL IN SYNTHESIS OF RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1993-11-25 | — | — | WO | claimed |